<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Blood product and extracorporeal procedure informed consent checklist</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Blood product and extracorporeal procedure informed consent checklist</h1>
<div class="graphic"><div class="figure"><div class="ttl">Blood product and extracorporeal procedure informed consent checklist</div><div class="cntnt"><table cellspacing="0"><colgroup width="80%"></colgroup><colgroup span="2" width="10%"></colgroup> <tbody> <tr> <td class="subtitle1_single" colspan="3">The following points can be documented:</td> </tr> <tr> <td class="indent1" colspan="3">Discussed the risks and benefits of accepting blood product transfusion.</td> </tr> <tr> <td class="indent1" colspan="3">Discussed the risks and benefits of NOT accepting blood product transfusion.</td> </tr> <tr> <td class="indent1" colspan="3">Discussed the risks and benefits of extracorporeal circulatory and salvage techniques.</td> </tr> <tr> <td class="indent1" colspan="3">Specify whether consent was obtained privately or with family members/others present.</td> </tr> <tr> <td class="indent1" colspan="3">Patient understands that if clinically significant bleeding cannot be stopped, then the patient will eventually die.</td> </tr> <tr> <td class="indent1" colspan="3">Patient is aware that blood product refusal may result in organ or tissue damage or even death.</td> </tr> <tr> <td class="indent1" colspan="3">Patient adamantly refuses the blood component therapies indicated below, even if faced with death.</td> </tr> <tr> <td class="indent1" colspan="3">Patient realizes that with these restrictions, the care team may be forced to proceed more quickly to definitive procedures that have a chance of stopping the bleeding (bowel resection, cesarean delivery, hysterectomy, amputation, etc) (this is due to the lack of a blood "buffer" that enables the treating team to replace the blood lost during preliminary attempts at hemostasis).</td> </tr> <tr> <td class="indent1" colspan="3">Patient understands that he or she may reverse these restrictions at ANY time and accept blood. If this occurs, the care team will abide by all patient privacy standards and not discuss the acceptance of blood products in front of family or clergy without patient consent.</td> </tr> <tr> <td class="indent1" colspan="3">Patient was given the option to allow blood transfusion in extremis if two physicians agree that death is likely imminent.</td> </tr> <tr> <td class="indent1" colspan="3">Another health care provider was present during the consent process or, alternatively, was present when the patient verbally acknowledged the summary of acceptable and unacceptable products and interventions.</td> </tr> <tr> <td class="subtitle1_single" colspan="3"><span style="white-space: nowrap;">Patient acceptance (Yes) or refusal (No) of the following items can be documented:</span></td> </tr> <tr> <td class="subtitle2_single" colspan="3">Allogenic human blood and blood components</td> </tr> <tr> <td class="indent1"> <ul> <li>Whole blood</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Red blood cells</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Plasma</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Platelets</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>White blood cells (granulocytes)</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Blood from specific donor(s)</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="subtitle2_single" colspan="3">Human blood fractions and medications that contain human blood fractions</td> </tr> <tr> <td class="indent1"> <ul> <li>Cryoprecipitate</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Cryosupernatant ("cryo-poor plasma")</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Albumin</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Plasma protein fraction</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Human immunoglobulin (eg, Rh immune globulin, IVIG)</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Plasma-derived clotting factor concentrates (eg, fibrinogen, factor VIII [F8], factor IX [F9])</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Tissue adhesives/fibrin glue</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="subtitle2_single" colspan="3">Intravenous fluids and medications not derived from human blood</td> </tr> <tr> <td class="indent1"> <ul> <li>Hydroxyethyl starch (eg, hetastarch, pentastarch)</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Balanced salt solutions</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Recombinant clotting factor concentrates (eg, factor VIII [F8], factor IX [F9], recombinant activated factor VII [rFVIIa; rF7a])</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Recombinant erythropoietin</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Antifibrinolytic chemicals (eg, tranexamic acid, aminocaproic acid)</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Chemicals to improve clotting (eg, desmopressin [DDAVP], vitamin K)</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="subtitle2_single" colspan="3">Extracorporeal techniques for blood conservation or treatment</td> </tr> <tr> <td class="indent1"> <ul> <li>Intraoperative hemodilution</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Intraoperative blood salvage (cell saver)</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Autologous banked blood (self donation)</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Cardiopulmonary bypass</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Chest drainage autotransfusion</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Plasmapheresis</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Hemodialysis</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> <tr> <td class="indent1"> <ul> <li>Other: ____________________________________________</li> </ul> </td> <td><span class="primarybox_left"> </span>Yes</td> <td><span class="primarybox_left"> </span>No</td> </tr> </tbody></table></div><div class="graphic_lgnd">This information is for use with patients who desire to restrict the use of blood products. Refer to UpToDate for futher information regarding the management of a patient who declines blood transfusion.</div><div class="graphic_footnotes">IVIG: intravenous immune globulin.</div><div class="graphic_reference">Courtesy of Kendall P Crookston, MD.</div><div id="graphicVersion">Graphic 106229 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
